• Je něco špatně v tomto záznamu ?

Structural basis for antibiotic resistance mediated by the Bacillus subtilis ABCF ATPase VmlR

C. Crowe-McAuliffe, M. Graf, P. Huter, H. Takada, M. Abdelshahid, J. Nováček, V. Murina, GC. Atkinson, V. Hauryliuk, DN. Wilson,

. 2018 ; 115 (36) : 8978-8983. [pub] 20180820

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19000438
E-zdroje Online Plný text

NLK Free Medical Journals od 1915 do Před 6 měsíci
Freely Accessible Science Journals od 1915 do Před 6 měsíci
PubMed Central od 1915 do Před 6 měsíci
Europe PubMed Central od 1915 do Před 6 měsíci
Open Access Digital Library od 1915-01-15
Open Access Digital Library od 1915-01-01

Odkazy

PubMed 30126986
DOI 10.1073/pnas.1808535115
Knihovny.cz E-zdroje

Many Gram-positive pathogenic bacteria employ ribosomal protection proteins (RPPs) to confer resistance to clinically important antibiotics. In Bacillus subtilis, the RPP VmlR confers resistance to lincomycin (Lnc) and the streptogramin A (SA) antibiotic virginiamycin M (VgM). VmlR is an ATP-binding cassette (ABC) protein of the F type, which, like other antibiotic resistance (ARE) ABCF proteins, is thought to bind to antibiotic-stalled ribosomes and promote dissociation of the drug from its binding site. To investigate the molecular mechanism by which VmlR confers antibiotic resistance, we have determined a cryo-electron microscopy (cryo-EM) structure of an ATPase-deficient B. subtilis VmlR-EQ2 mutant in complex with a B. subtilis ErmDL-stalled ribosomal complex (SRC). The structure reveals that VmlR binds within the E site of the ribosome, with the antibiotic resistance domain (ARD) reaching into the peptidyltransferase center (PTC) of the ribosome and a C-terminal extension (CTE) making contact with the small subunit (SSU). To access the PTC, VmlR induces a conformational change in the P-site tRNA, shifting the acceptor arm out of the PTC and relocating the CCA end of the P-site tRNA toward the A site. Together with microbiological analyses, our study indicates that VmlR allosterically dissociates the drug from its ribosomal binding site and exhibits specificity to dislodge VgM, Lnc, and the pleuromutilin tiamulin (Tia), but not chloramphenicol (Cam), linezolid (Lnz), nor the macrolide erythromycin (Ery).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19000438
003      
CZ-PrNML
005      
20190111151701.0
007      
ta
008      
190107s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1073/pnas.1808535115 $2 doi
035    __
$a (PubMed)30126986
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Crowe-McAuliffe, Caillan $u Institute for Biochemistry and Molecular Biology, University of Hamburg, 20146 Hamburg, Germany.
245    10
$a Structural basis for antibiotic resistance mediated by the Bacillus subtilis ABCF ATPase VmlR / $c C. Crowe-McAuliffe, M. Graf, P. Huter, H. Takada, M. Abdelshahid, J. Nováček, V. Murina, GC. Atkinson, V. Hauryliuk, DN. Wilson,
520    9_
$a Many Gram-positive pathogenic bacteria employ ribosomal protection proteins (RPPs) to confer resistance to clinically important antibiotics. In Bacillus subtilis, the RPP VmlR confers resistance to lincomycin (Lnc) and the streptogramin A (SA) antibiotic virginiamycin M (VgM). VmlR is an ATP-binding cassette (ABC) protein of the F type, which, like other antibiotic resistance (ARE) ABCF proteins, is thought to bind to antibiotic-stalled ribosomes and promote dissociation of the drug from its binding site. To investigate the molecular mechanism by which VmlR confers antibiotic resistance, we have determined a cryo-electron microscopy (cryo-EM) structure of an ATPase-deficient B. subtilis VmlR-EQ2 mutant in complex with a B. subtilis ErmDL-stalled ribosomal complex (SRC). The structure reveals that VmlR binds within the E site of the ribosome, with the antibiotic resistance domain (ARD) reaching into the peptidyltransferase center (PTC) of the ribosome and a C-terminal extension (CTE) making contact with the small subunit (SSU). To access the PTC, VmlR induces a conformational change in the P-site tRNA, shifting the acceptor arm out of the PTC and relocating the CCA end of the P-site tRNA toward the A site. Together with microbiological analyses, our study indicates that VmlR allosterically dissociates the drug from its ribosomal binding site and exhibits specificity to dislodge VgM, Lnc, and the pleuromutilin tiamulin (Tia), but not chloramphenicol (Cam), linezolid (Lnz), nor the macrolide erythromycin (Ery).
650    _2
$a ABC transportéry $x chemie $x genetika $x metabolismus $7 D018528
650    _2
$a alosterická regulace $x účinky léků $x genetika $7 D000494
650    _2
$a antibakteriální látky $x chemie $x farmakologie $7 D000900
650    _2
$a Bacillus subtilis $x enzymologie $x genetika $7 D001412
650    _2
$a bakteriální proteiny $x chemie $x genetika $x metabolismus $7 D001426
650    12
$a bakteriální léková rezistence $7 D024881
650    _2
$a RNA transferová $x chemie $x genetika $x metabolismus $7 D012343
650    _2
$a ribozomy $x chemie $x genetika $x metabolismus $7 D012270
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Graf, Michael $u Institute for Biochemistry and Molecular Biology, University of Hamburg, 20146 Hamburg, Germany.
700    1_
$a Huter, Paul $u Institute for Biochemistry and Molecular Biology, University of Hamburg, 20146 Hamburg, Germany.
700    1_
$a Takada, Hiraku $u Department of Molecular Biology, Umeå University, 90187 Umeå, Sweden. Laboratory for Molecular Infection Medicine Sweden, Umeå University, 90187 Umeå, Sweden.
700    1_
$a Abdelshahid, Maha $u Institute for Biochemistry and Molecular Biology, University of Hamburg, 20146 Hamburg, Germany.
700    1_
$a Nováček, Jiří $u Central European Institute of Technology, Masaryk University, 62500 Brno, Czech Republic.
700    1_
$a Murina, Victoriia $u Department of Molecular Biology, Umeå University, 90187 Umeå, Sweden.
700    1_
$a Atkinson, Gemma C $u Department of Molecular Biology, Umeå University, 90187 Umeå, Sweden.
700    1_
$a Hauryliuk, Vasili $u Department of Molecular Biology, Umeå University, 90187 Umeå, Sweden. Laboratory for Molecular Infection Medicine Sweden, Umeå University, 90187 Umeå, Sweden. Institute of Technology, University of Tartu, 50411 Tartu, Estonia.
700    1_
$a Wilson, Daniel N $u Institute for Biochemistry and Molecular Biology, University of Hamburg, 20146 Hamburg, Germany; daniel.wilson@chemie.uni-hamburg.de.
773    0_
$w MED00010472 $t Proceedings of the National Academy of Sciences of the United States of America $x 1091-6490 $g Roč. 115, č. 36 (2018), s. 8978-8983
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30126986 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20190111151906 $b ABA008
999    __
$a ok $b bmc $g 1363844 $s 1038561
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 115 $c 36 $d 8978-8983 $e 20180820 $i 1091-6490 $m Proceedings of the National Academy of Sciences of the United States of America $n Proc Natl Acad Sci U S A $x MED00010472
LZP    __
$a Pubmed-20190107
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace